5Schofer J,Schluter M,Gershlick AH. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries:double-blind,randomized controlled trial(E-SIRIUS)[J].{H}LANCET,2003.1093-1099.
6Schampaert E,Cohen EA,Schluter M. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries(C-SIRIUS)[J].{H}Journal of the America College of Cardiology,2004.1110-1115.
7Kastrati A,Schomig A,Elezi S. Predictive factors of restenosis atfter coronary stent placement[J].J Am Coll Car-diol,1997.1428-1431.
8Kastrati A,Schomig A,Dirschinger J. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease[J].{H}CIRCULATION,2000.2593-2598.
9Umeda H,Iwase M,Gochi T. Safety and efficacy of 2.5-mm sirolimus-eluting stent implantation at lower deployment pressures in very small vessels(《2.5 mm)[J].{H}Coronary Artery Disease,2009.163-168.
10Kobayashi Y,De Gregorio J,Kobayashi N. Stented segment length as an independent predictor of restenosis[J].{H}Journal of the America College of Cardiology,1999.651-653.
